medigraphic.com
ISSN 2078-7162 (Print)

2015, Number 2

<< Back Next >>

Rev Cub de Med Fis y Rehab 2015; 7 (2)

Utility of the magnetic therapy and the ion cleanse in the treatment of the drop

Varela OS, Pérez RZM, Mora GSR

Language: Spanish
References: 27
Page: 172-181
PDF size: 139.13 Kb.


ABSTRACT

Objetive: to determine the utility in the decrease of the uric acid, the pain and inflammation in the treatment with magnetic fields and ion cleanse in the patients with drop.
Method: an experimental study, in 90 patients, the sample was divided in three groups of 30 patients each one. The group 1 (control) received pharmacological treatment, hygienic-dietary measures and control of the toxic habits. The group 2 treaties with ion cleanse, 30 min in 28 sessions (2 of 14 sessions with intervals of 15-21 days) and the group 3 was indicated magnetic bed 50Hz 100% in the painful area. To the group 2 and 3 they were guided hygienic-dietary measures and control of the toxic habits similar to the group 1. To evaluate the effectiveness of the treatment, before and later, the patients were evaluated by clinic (test of Likert for pain and inflammation and physical exam) and complementary studies (uric acid). The three groups were evaluated in 30 session-days. In the processing of the qualitative variables the test was used squared Chi or Mac Nemar in the case of the related ones and for the quantitative ones it was used the test of Student and K. Wallis. The level of statistical significance a value p ≤ 0,05.
Results: at the end of the treatment the pain and the inflammation was absent in most of the patients in the three groups absent. The uric acid after the treatment the half value diminished.
Conclusions: the magnetic field and the ion cleanse was useful in the decrease of the uric acid and the symptoms and signs of patient with drop.


REFERENCES

  1. Gómez-Puerta J A, Gota: nuevos conceptos patogénicos y nuevos agentes terapéuticos. Rev Colomb Reumatol. 2011;18(3):163-74.

  2. Castro M, Rojas K, Actualización en el manejo de hiperuricemia/crisis aguda de gota. Medicina Interna. Rev Med Costa Rica y Centroam. 2011;68(597):183-7.

  3. Janssens HJ, Janssen M, van de Lisdonk EH, Fransen J, van Riel PL, van Weel C. Limited validity of the American College of Rheumatology criteria for classifying patients with gout in primary care. Ann Rheum Dis. 2010;69:1255–6.

  4. Castelar G, Reverendo a orientação dietética na gota, Revista Brasileña Reumatología .2008:48(3), junio. São Paulo.

  5. Annemans L, Spaegen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T, et al. Gout in the UK and Germany: Prevalence, comorbilities and management in general practice, 2000-2005. Ann Rheum Dis. 2008; 67: 960-6.

  6. Sicras- Mainar A, Navarro R, Ibáñez J, Uso de recursos e impacto económico de los pacientes con Gota: estudio multicéntrico de ámbito poblacional. Reumatol Clin. 2013; 9(2): 94-100. Disponible en: www.reumatologiaclinica.org

  7. Luño J; Goicoechea M; García- De Vinuesa S. Introducción: Avances en el tratamiento de la Gota. Revista Nefrología. 8/Junio /2012; vol. 3 No. 2: 1-7. Disponible en: http://www.revistanefrologia.com. Consultado noviembre 15, 2012.

  8. Cruz E. Incide la alimentación en enfermedad conocida como Gota. Hospital General Zona # 1 del Instituto Mexicano de Seguro Social (IMSS). Tapachula. 2010. Disponible en: http://boletinaldía.sld.cu/

  9. So A. Epidemiology: gout-bad for the heart as well as the joint. Nat Rev Rheumatol. 2010; 6: 386-7.

  10. Goicoechea M, García-De Vinuesa S, Arroyo D, Luño J; Hiperuricemia, gota y enfermedad renal crónica, revista Nefrología/Suplemento Extraordinario, 2012; 3(2): 8-15. Disponible en: http://www.revistanefrologia.com

  11. Chao J, Terkeltaub R: A critical 3. Reappraisal of allopurinol dosing, safety, and efficacy for hyperuricemia in gout. Curr Rheumatol Rep. 2009;11:135-40

  12. Martínez Martínez Y, Pérez Rodríguez ZM, Mora González SR, Rodríguez Apolinario N, González Ramos O. Utilidad de la magnetoterapia y el ion cleanse en pacientes con enfermedad renal crónica secundaria. Rev Cubana Med Fis Rehab. 2013Ene;5(1) Disponible en: http://bvs.sld.cu/revistas/mfr/vol_5n113/mfrsu 1213.htm

  13. Goodman R, Blank M. Insights into electromagnetic interaction mechanisms. J Cell Physiol. 2002 Jul; 192(1):16-22.

  14. Ohata R, Tomita N, Ikada Y. Effect of a static magnetic field on ion transport in a cellulose membrane. J Colloid Interface Sci. 2004; 270:413–416.

  15. Yamamoto T, Nagayama Y, Tamura M. 2004. A blood-oxygenation dependent increase in blood viscosity due to a static magnetic field. Phys Med Biol 49:3267–77.

  16. Martínez Escudero C, Capellas Sans L, Tinoco González J. Magnetoterapia en retardos de consolidación Rehabilitación 2001; 35 (05):312-4.

  17. BHL Ion Cleanse Toxin Draining Device Cref-International service, SA. Revisado en octubre- nov. 2012. Disponible en: www.drenatoxinas.com, http://eliumfoundation.org.

  18. López M, García J. Diagnóstico y tratamiento/gota úrica. Med Clin (Barc). 2004; 123(4);138-42.

  19. Restrepo J P, Pascual E. Gota en el anciano. Rev Colombiana Reumatol. 2008 marzo; 15(1):12-9. Disponible en: http://www.revistareumatología.com

  20. Pascual E, Sivera F. Therapeutic advances in gout. Curr Opin Rheumatol 2007;19: 122-7.

  21. Arromdie E, Michet CJ, Crowson CS, O̍ Fallow WM, Gabriel SE: Epidemiology of gout: is the incidence rising. J Rheumatol 2002;29:2403-6.

  22. Talavera F, Brent LH, Mechaber AJ, Diamond HS. Gota. New York: 2009. 15;2:16-8.

  23. Whelton A, Mac Donald Pa, Zhao L, Hunt B, Gunawardhara L. Renal function in gout. Long-term treatment effects of febuxostat. J Clin Rheumatol 2011;17:7- 13.[Pubmed]

  24. Sancho T. García J. Comentario clínico, criterios terapéuticos ante la hiperuricemia. Rev Clín Esp. 2001-feb; 201(2):85-7.

  25. Pérez Rodríguez ZM: Magnetoterapia y ejercicios en pacientes con insuficiencia arterial crónica de miembros inferiores. Rev Cubana Med Fis Rehab [revista en la Internet]. 2010 May;2(1) Disponible en: http://www.sld.cu/articulos.sld.cu/ revrehabilitacion/&post_id=167&c=3734&tipo=2&idblog=110&p=1&n=dee

  26. Domínguez Iglesias M.; Pérez Rodríguez Z.M. Magnetoterapia en pacientes con gastritis crónica antral. Rev Cubana Med Militar. 2012;41(3):283-91. Disponible en: http://scielo.sld.cu

  27. Bordiushkov IN, et al. Structural-funcional changes in lymphocyte and erythrocyte membranes after exposure to alterning manetic field. Vopr Med Khim 2000 Jan-Feb;46910:72-80.




2020     |     www.medigraphic.com